Selank and semax for ADHD and anxiety: what the science says
Quick answer
Semax and Selank are synthetic peptides with preliminary evidence for cognitive and anxiolytic effects respectively, primarily from preclinical and small Russian clinical trials. Neither has FDA approval for any indication, and their use in conditions like ADHD or generalized anxiety disorder has not been established through rigorous human trials. On a regulated telehealth platform, either peptide would require a thorough provider evaluation before any consideration of appropriateness for an individual patient.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.
What did @_life_with_kaitlyn actually say?
The short version: Semax is your "superhero push" for focus and "battling brain fog," and Selank is "like the hug for your brain" that brings down anxiety and overwhelm. She frames them as two complementary peptides serving opposite neurological roles, one stimulating, one calming, and suggests both help with stress and focus through different mechanisms.
She mispronounces both peptides throughout, calling them "C-Max" and "C-Link," which matters more than it sounds. When you're directing an audience of 11,000 people toward compounds they'll be searching for and potentially sourcing themselves, accuracy in naming is a basic floor. That said, the conceptual framing she offers isn't entirely off base, which we'll get into.
Does the science back this up?
Partially, but the evidence base here is weaker than a TikTok playground analogy implies. Most of the research on both peptides is preclinical or comes from small Russian trials, which should be your first caution flag before anyone messages her for a "trusted source."
Semax is a synthetic heptapeptide derived from ACTH(4-7) that has been studied for its effects on brain-derived neurotrophic factor (BDNF) and dopaminergic activity. Dolotov et al. (2006, Journal of Neurochemistry) found Semax increased BDNF expression in rat brain tissue, which is at least a plausible mechanism for the focus and cognitive effects she describes. Human trials are limited and mostly from Russian clinical settings studying stroke recovery, not healthy adults chasing focus.
Selank is a synthetic analogue of the endogenous peptide tuftsin and has shown anxiolytic effects in animal models and some small human studies. Kasian et al. (2012, Bulletin of Experimental Biology and Medicine) reported reductions in anxiety measures in patients with generalized anxiety disorder. That supports her "calming" framing, though calling it a brain "hug" significantly undersells the regulatory uncertainty here.
What did they get wrong (or right)?
She gets the directional split roughly right: Semax trends toward cognitive stimulation, Selank trends toward anxiolytic effects. Credit where it's due. But several things deserve pushback.
First, saying Semax is "good for battling brain fog" in the context of ADHD hashtags implies these peptides are treatments for ADHD. They are not FDA-approved for that indication, and no peer-reviewed human trial has established either compound as an ADHD treatment. Framing a research compound this way to an audience already searching #adhd is irresponsible.
Second, the "two very different roles" framing makes the pharmacology sound cleaner than it is. Selank has also shown effects on serotonin and dopamine metabolism (Semenova et al., 2010, CNS Drug Reviews), meaning its activity overlaps with Semax in ways she doesn't acknowledge. These are not simple on/off switches.
Third, and most importantly: she tells viewers to "message me" for a trusted source. That is not how regulated healthcare works. Peptide sourcing is a serious quality and safety issue. Unverified vendors sell products with wildly variable purity.
What should you actually know?
Both Semax and Selank are unscheduled in the United States but are not FDA-approved drugs. They exist in a regulatory gray zone, often sold as "research chemicals." That label is not a safety endorsement. It means they haven't been through the clinical trial process required to establish safe dosing, drug interactions, or long-term effects in humans.
If you're experiencing anxiety, ADHD symptoms, or cognitive difficulties, those are clinical presentations that warrant a conversation with a licensed provider, not a TikTok DM. A telehealth provider can evaluate whether peptide therapy is appropriate, discuss the actual evidence base, and connect you with a compounding pharmacy operating under quality standards.
- Neither peptide is a substitute for evidence-based treatment of anxiety or ADHD.
- Quality control varies enormously across peptide suppliers. Purity testing matters.
- The "calming vs. stimulating" framing is a simplification that could lead people to self-select the wrong compound for their situation.
- Sourcing peptides from unverified vendors based on social media recommendations carries real risk.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 6 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For Selank and semax for ADHD and anxiety: what the science says, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Functional Connectomic Approach to Studying Selank and Semax Effects
Small Russian fMRI study (52 healthy volunteers) of brain connectivity after Semax or Selank; mechanistic and exploratory, not a clinical efficacy trial.
PubMed
Effects of Semax on the Default Mode Network of the Brain
Small human fMRI study (24 adults) of intranasal Semax on brain networks; an imaging-marker study with no clinical outcomes, not replicated outside the originating group.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
Selank and semax for ADHD and anxiety: what the science says is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
Compare providers, services and access requirements in the directory before contacting a suitable care team.
Helpful context before the funnel
Claim verdict
The useful answer behind this video
Claim being checked
Semax and Selank are synthetic peptides with preliminary evidence for cognitive and anxiolytic effects respectively, primarily from preclinical and small Russian clinical trials.
FormBlends verdict
Semax and Selank are synthetic peptides with preliminary evidence for cognitive and anxiolytic effects respectively, primarily from preclinical and small Russian clinical trials. Neither has FDA approval for any indication, and their use in conditions like ADHD or generalized anxiety disorder has not been established through rigorous human trials. On a regulated telehealth platform, either peptide would require a thorough provider evaluation before any consideration of appropriateness for an individual patient.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- Semax and Selank are synthetic peptides with preliminary evidence for cognitive and anxiolytic effects respectively, primarily from preclinical and small Russian clinical trials. Neither has FDA approval for any indication, and their use in conditions like ADHD or generalized anxiety disorder has not been established through rigorous human trials. On a regulated telehealth platform, either peptide would require a thorough provider evaluation before any consideration of appropriateness for an individual patient.
- Semax is derived from ACTH(4-7) and increased BDNF expression in rat brain tissue in Dolotov et al. (2006), but no human RCT has tested it for ADHD or general cognitive enhancement in healthy adults.
- Selank showed statistically significant reductions in anxiety scores in a small GAD patient trial (Kasian et al., 2012), giving its 'calming' reputation at least some human evidence, though the sample sizes were small.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- Semax is derived from ACTH(4-7) and increased BDNF expression in rat brain tissue in Dolotov et al. (2006), but no human RCT has tested it for ADHD or general cognitive enhancement in healthy adults.
- Selank showed statistically significant reductions in anxiety scores in a small GAD patient trial (Kasian et al., 2012), giving its 'calming' reputation at least some human evidence, though the sample sizes were small.
- Neither Semax nor Selank is FDA-approved for any indication. Both occupy a regulatory gray zone in the U.S. and are commonly sold as research chemicals without standardized quality controls.
- Selank affects serotonin and dopamine metabolism in addition to its anxiolytic effects (Semenova et al., 2010, CNS Drug Reviews), meaning the clean 'calm vs. focus' split the video describes is an oversimplification.
- Peptide purity varies significantly across unregulated vendors. A 2018 analysis of research peptides found substantial discrepancies between labeled and actual content across multiple suppliers.
- ADHD and generalized anxiety disorder are clinical diagnoses. Social media peptide recommendations are not a substitute for evaluation by a licensed provider who can assess individual risk factors and contraindications.
- If you are considering Semax or Selank, a regulated telehealth provider can review your history, discuss the actual evidence, and connect you with a licensed compounding pharmacy rather than an unverified online source.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
_life_with_kaitlyn · TikTok creator
11.2K views on this video
If you need a trusted source message me 🫶🏻 #selank #semax #focus #anxiety #adhd
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by _life_with_kaitlyn, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.